← Alle mensen

MR

Margitta Retz

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemoth...

The Lancet. Oncology · 2026-01

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer:...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 mei 2025

Pembrolizumab plus olaparib bij biomarker-ongeselecteerd mCRPC: KEYLYNK-010 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 augustus 2023

Sunitinib-sorafenib versus sorafenib-sunitinib sequentie bij niercelcarcinoom: SWITCH II fase III

European journal of cancer (Oxford, England : 1990) · 2019-01